Europe’s women are much more likely to survive a cancer diagnosis than their male counterparts. According to EUROCARE-4, after adjusting for age and casemix, 54.6% of the women diagnosed between 1995 and 1999 survived for at least five years, but only 44.8% of men. The gap is the more worrying because, while differences in survival rates between countries have shown a welcome decrease since EUROCARE-3 (patients diagnosed 19901994), the gender gap has remained exactly the same, at 11.4 percentage points.
Leave a Reply